Benign neoplasm: Rectum, anus and anal canal

CD2_BENIGN_RECTUM_ANAL

rectum cancer: A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_RECTUM CD2_BENIGN_ANUS_ANAL_CANAL CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9	8131
6. Filter based on genotype QC (FinnGen only)	8131

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_RECTUM_ANAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_RECTUM\|CD2_BENIGN_ANUS_ANAL_CANAL\|CD2_BENIGN_RECTUM_ANAL_CANAL_ICD9
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Rectum, anus and anal canal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	46435	23043	23086
Only index persons	41450	21048	20402
Unadjusted period prevalence (%)
Whole population	0.65	0.66	0.65
Only index persons	0.78	0.77	0.78
Median age at first event (years)
Whole population	65.74	65.69	65.75
Only index persons	65.19	65.09	65.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8131	3869	4262
Unadjusted period prevalence (%)	1.61	1.32	1.88
Median age at first event (years)	65.13	63.46	66.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7150: Matched controls
71504

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

9.5

323.0

770

894

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

1745.8

323.0

900

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.7

323.0

2386

8602

UJF32

NOMESCO Finland

Coloscopy

9.8

323.0

4866

12765

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4056.3

323.0

6138

104

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

9.4

323.0

2114

3066

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

10.8

323.0

1170

1275

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

6.7

323.0

1089

1865

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

11.1

323.0

670

660

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

15.3

323.0

1899

1654

UJF30

NOMESCO Finland

Ileoscopy through colon

4.8

323.0

1437

3561

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

12.5

307.6

575

496

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

274.2

2876

14805

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

41.3

252.9

320

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

8.4

243.3

566

726

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

353.1

239.8

241

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

10.7

216.0

435

431

UJG02

NOMESCO Finland

Proctoscopy

8.7

201.4

455

553

21140

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Rectum

+∞

189.4

181

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

15.0

164.9

282

195

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

3.2

151.8

879

2969

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

6.1

150.7

435

751

JHA20

NOMESCO Finland

Excision of lesion of anal canal or perianal tissue

12.4

149.7

278

232

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

146.4

2120

11873

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

273.9

131.6

134

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

10.8

127.1

252

240

UJH02

NOMESCO Finland

Anoscopy

4.1

125.9

524

1342

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

6.1

125.3

361

620

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.4

122.6

654

2063

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

117.8

2527

16160

K62.1

ICD-10 Finland

Rectal polyp

10.4

115.9

234

231

A02BC02

ATC

pantoprazole; systemic

1.8

109.1

4752

37770

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.2

95.1

538

1762

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

90.7

956

4515

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

12.0

89.6

168

143

N02BE01

ATC

paracetamol; systemic, rectal

1.9

87.6

6099

53789

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

86.8

3358

24992

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

288.3

83.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

81.8

919

4454

P01AB01

ATC

metronidazole; oral, rectal

1.7

80.3

2649

18741

WX002

NOMESCO Finland

Sedation and analgesia

1.8

79.0

1594

9710

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

73.9

1987

13192

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.8

73.4

509

1902

JN4BD

NOMESCO Finland

Extensive body CT

2.0

70.9

970

5096

C05AA08

ATC

fluocortolone; rectal, topical

1.9

69.3

1114

6229

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

5.1

68.3

224

448

JFA42

NOMESCO Finland

Endoscopic injection in colon

15.2

68.3

115

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

67.0

1557

9844

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

80.9

64.1

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

12.8

63.6

115

JG1CG

NOMESCO Finland

Extensive MRI of rectum

11.2

63.2

122

111

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.8

63.1

444

1670

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

4.9

62.5

212

440

J01DB01

ATC

cefalexin; oral

1.6

62.4

5497

48205

2114X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[NEOPLASMA BENIGNUM ALIUD RECTI ET CANALIS ANALIS]

+∞

60.5

B01AB05

ATC

enoxaparin; parenteral

1.6

60.4

2272

16305

K62.0

ICD-10 Finland

Anal polyp

6.7

59.8

158

242

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

58.9

666

3211

K92.1

ICD-10 Finland

Melaena

2.5

58.9

480

1967

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

57.6

1237

7587

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.3

57.0

553

2481

N02AX02

ATC

tramadol; systemic, rectal

1.5

55.5

3000

23275

A02BC05

ATC

esomeprazole; systemic

1.5

55.1

2764

21083

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

6.9

54.6

140

206

2114C

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA TUBULARE RECTI ET CANALIS ANALIS]

+∞

52.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

51.8

570

2709

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

8.6

51.7

115

136

JG1BG

NOMESCO Finland

MRI of rectum

7.6

50.1

120

160

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

50.0

1487

9965

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

49.9

956

5626

JHB00

NOMESCO Finland

Hemorrhoidectomy

3.1

48.4

286

961

R4110

NOMESCO Finland

Physiotherapy

1.5

47.9

1843

13134

N03AX16

ATC

pregabalin; oral

1.6

47.4

1606

11098

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

47.3

824

4691

JFF23

NOMESCO Finland

Transversostomy

5.4

46.3

144

272

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

46.2

1060

6588

H02AB06

ATC

prednisolone; systemic

1.4

45.5

3155

25378

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

7.9

43.7

102

131

J01MA02

ATC

ciprofloxacin; systemic

1.4

42.3

2672

21017

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

42.2

766

4411

A02BC03

ATC

lansoprazole; oral

1.5

42.0

2034

15165

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

10.2

42.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

41.7

2125

16005

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

8.0

41.7

121

R03AC02

ATC

salbutamol; inhalant

1.4

41.5

3238

26458

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

11.2

41.4

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

8.0

40.4

117

S18

ICPC

Laceration/cut

1.4

39.1

2879

23188

WX402

NOMESCO Finland

General anaesthesia

1.6

39.0

1037

6692

K64.0

ICD-10 Finland

First degree haemorrhoids

4.7

38.8

135

290

M79.6

ICD-10 Finland

Pain in limb

1.4

38.1

2258

17444

D01

ICPC

Abdominal pain/cramps general

1.9

38.1

630

3509

L01BC06

ATC

capecitabine; oral

2.5

37.8

307

1252

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

3.0

37.8

234

809

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

37.6

1867

13928

R06.0

ICD-10 Finland

Dyspnoea

1.5

37.2

1697

12433

M54.5

ICD-10 Finland

Low back pain

1.4

36.4

1962

14857

WX110

NOMESCO Finland

Local anesthesy

1.4

35.8

4223

36635

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

4.0

35.6

145

364

2114A

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA VILLOSUM RECTI ET CANALIS ANALIS]

+∞

35.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

35.2

1300

9078

I84.5

ICD-10 Finland

External hemorrhoids without complication

2.7

34.4

246

932

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

34.2

1015

6720

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

34.2

1456

10486

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

33.8

2253

17693

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

5.9

33.5

162

K63.5

ICD-10 Finland

Polyp of colon

4.1

33.3

133

328

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

33.3

235

883

A02BC01

ATC

omeprazole; systemic

1.4

33.3

1865

14180

C209, 8211, 2

ICD-O-3

74.5

32.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

32.6

542

3022

J01CA04

ATC

amoxicillin; systemic

1.4

32.2

5066

45637

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

32.2

762

4743

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

32.5

32.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

32.1

3001

24883

Z93.3

ICD-10 Finland

Colostomy status

5.1

31.3

100

197

JHA10

NOMESCO Finland

Biopsy of anal canal

18.6

31.3

J01AA02

ATC

doxycycline; systemic

1.4

30.9

5147

46598

UJF92

NOMESCO Finland

Capsular endoscopy

3.3

30.6

162

506

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.8

30.5

200

722

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

6.3

30.3

132

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

4.1

30.2

120

295

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

11.3

30.2

N06AX11

ATC

mirtazapine; oral

1.4

30.1

1924

14926

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

29.8

636

3839

TJG20

NOMESCO Finland

Transanal irrigation

16.9

29.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

29.5

2203

17540

D11

ICPC

Diarrhoea

1.8

29.4

570

3340

AA1AD

NOMESCO Finland

CT of head and brain

1.4

29.3

1632

12338

2114B

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Rectum and anal canal[ADENOMA TUBULOVILLOSUM RECTI ET CANALIS ANALIS]

+∞

29.2

D16

ICPC

Rectal bleeding

3.0

29.2

174

590

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

28.8

921

6190

JN4AD

NOMESCO Finland

Body CT examination

1.8

28.7

565

3328

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

28.4

249

1057

J01DA01

ATC

[U] cefalexin; systemic

1.3

28.0

3958

34633

G04CA02

ATC

tamsulosin; oral

1.4

28.0

1700

13040

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

9.4

27.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

27.4

609

3716

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.7

27.2

557

3315

UKC02

NOMESCO Finland

Cystoscopy

1.5

27.1

1181

8491

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

26.9

2875

24101

A07EC02

ATC

mesalazine; oral, rectal

2.1

26.8

329

1632

A06AC51

ATC

ispaghula, combinations; systemic

2.0

26.7

346

1758

JHA00

NOMESCO Finland

Anal or perianal incision

3.9

26.5

110

283

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

7.6

25.9

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.3

25.8

131

397

XKD00

NOMESCO Finland

Uroflowmetry

1.4

25.7

1196

8704

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

25.5

1186

8633

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.2

25.1

154

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

24.9

325

1653

N05CF01

ATC

zopiclone; oral

1.3

24.3

2101

17000

D06

ICPC

Abdominal pain localized other

1.8

24.2

458

2662

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

24.0

4143

36869

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.2

23.9

254

1184

R35

ICD-10 Finland

Polyuria

1.8

23.9

445

2568

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

23.7

2370

19570

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.6

23.5

180

714

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

23.5

1062

7674

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

23.4

266

1280

M25.5

ICD-10 Finland

Pain in joint

1.4

23.3

1574

12230

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

23.0

242

1124

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

22.9

239

1107

A98

ICPC

Health maint/preventive medicine

1.5

22.9

6408

61067

D18

ICPC

Change in faeces/bowel movements

2.6

22.7

164

630

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

22.4

244

1154

N06AB04

ATC

citalopram; systemic

1.4

22.4

1255

9437

C209, 8148, 2

ICD-O-3

45.1

22.3

R03BB04

ATC

tiotropium bromide; inhalant

1.6

22.3

690

4589

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

16.7

22.2

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

3.4

22.2

108

319

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.4

21.9

189

798

M03BX02

ATC

tizanidine; oral

1.3

21.9

3606

31718

R51.80

ICD-10 Finland

Headache

1.5

21.9

735

4979

A02BA02

ATC

ranitidine; systemic

1.4

21.9

1302

9891

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

21.8

1098

8088

ZX120

NOMESCO Finland

Intravenous

1.6

21.7

595

3839

J45

ICD-10 Finland

Asthma

1.6

21.7

549

3466

C10AA05

ATC

atorvastatin; oral

1.3

21.6

2655

22473

K59.0

ICD-10 Finland

Constipation

1.8

21.5

375

2118

A07EA02

ATC

hydrocortisone; rectal

2.6

21.5

158

614

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

21.2

691

4648

UJF34

NOMESCO Finland

Left colonoscopy

4.4

21.2

176

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.3

21.2

106

320

N06AX21

ATC

duloxetine; oral

1.6

21.1

584

3775

D75

ICPC

Malignant neoplasm colon/rectum

4.5

21.1

168

H02AB07

ATC

prednisone; oral

1.5

20.9

879

6253

C07AB07

ATC

bisoprolol; oral

1.3

20.8

3280

28620

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.3

20.7

119

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

20.7

311

1674

K51.5

ICD-10 Finland

Left sided colitis

2.6

20.5

154

604

J01MA12

ATC

levofloxacin; systemic

1.4

20.4

1213

9194

M01AE02

ATC

naproxen; oral, rectal

1.3

20.4

3304

28894

R01AD09

ATC

mometasone; nasal

1.3

20.3

2450

20643

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

20.3

203

923

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

20.2

313

1699

K57

ICD-10 Finland

Diverticular disease of intestine

2.6

20.2

152

598

C03CA01

ATC

furosemide; systemic

1.3

20.1

2025

16644

ZXA00

NOMESCO Finland

Right side

1.3

20.1

1782

14388

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

20.0

550

3552

R53

ICD-10 Finland

Malaise and fatigue

1.4

19.9

1191

9040

G47.3

ICD-10 Finland

Sleep apnoea

1.4

19.8

1269

9736

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

19.8

4020

36071

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

9.2

19.8

L03

ICPC

Low back symptom/complaint

1.4

19.7

1363

10586

I84

ICD-10 Finland

Hemorrhoids

2.2

19.7

199

910

ZXA05

NOMESCO Finland

Left side

1.3

19.6

1656

13262

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

7.3

19.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

19.5

2581

21967

R15

ICD-10 Finland

Faecal incontinence

2.3

19.5

180

790

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

19.5

1250

9594

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

19.4

3528

31203

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

19.4

2379

20045

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

19.4

591

3909

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

19.3

393

2335

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

19.3

461

2865

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

19.2

295

1597

130

Kela drug reimbursment

Malignant tumour

1.6

19.2

570

3748

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

19.0

217

1049

SPAT1153

SPAT

Removal of sutures

1.3

19.0

2098

17432

WX892

NOMESCO Finland

Monitored bed care

1.6

18.8

488

3100

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

18.8

897

6533

Z71.8

ICD-10 Finland

Other specified counselling

1.4

18.8

1265

9780

K55.2

ICD-10 Finland

Angiodysplasia of colon

4.4

18.7

152

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

18.7

1535

12234

J02AC01

ATC

fluconazole; systemic

1.3

18.6

2062

17129

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

18.5

965

7137

C20

ICD-10 Finland

Malignant neoplasm of rectum

4.0

18.5

186

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

18.4

2940

25547

JF2BD

NOMESCO Finland

Extensive colon CT

3.4

18.3

259

N05BA04

ATC

oxazepam; oral

1.3

18.3

1418

11200

K60.2

ICD-10 Finland

Anal fissure, unspecified

3.0

18.1

107

365

JFB30

NOMESCO Finland

Right hemicolectomy

2.7

18.1

124

463

SPAT1301

SPAT

No procedures

1.3

18.0

1984

16452

J01FA06

ATC

roxithromycin; oral

1.3

18.0

2406

20449

K60.1

ICD-10 Finland

Chronic anal fissure

2.5

18.0

145

594

WX600

NOMESCO Finland

Single shot through catheter

3.2

17.9

306

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

17.9

1035

7791

K96

ICPC

Haemorrhoids

2.4

17.9

149

621

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

17.9

816

5885

A06AD11

ATC

lactulose; oral

1.4

17.9

934

6909

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

17.8

197

940

R19.4

ICD-10 Finland

Change in bowel habit

2.4

17.7

156

668

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

17.7

1963

16286

TJF80

NOMESCO Finland

Ostomy education

3.6

17.7

224

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

17.7

592

4000

N06AX16

ATC

venlafaxine; oral

1.5

17.7

658

4555

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

17.6

472

3028

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

17.6

224

1133

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

17.6

1533

12308

K02.1

ICD-10 Finland

Caries of dentine

1.2

17.4

3066

26883

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

17.3

637

4397

K60.3

ICD-10 Finland

Anal fistula

2.8

17.3

113

411

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

5.9

17.3

1471

FHL

Rectoscopy and polyp removal

18.6

17.3

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

17.3

156

678

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.5

17.3

131

520

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

17.2

5642

53126

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

17.1

696

4908

Z01.7

ICD-10 Finland

Laboratory examination

1.5

17.0

621

4280

WX320

NOMESCO Finland

Spinalanesthesy

1.3

17.0

1423

11349

R01AD08

ATC

fluticasone; nasal

1.3

16.9

1519

12237

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

16.8

988

7453

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

16.8

253

1361

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

16.8

893

6626

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

2972

7431

5.73

307.65

1.6

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1914

8027

2.81

304.84

4.8

4.0

ug/l

11.7

25.2

2.61

1611

6612

(3024561) Albumin [Mass/volume] in Serum or Plasma

4530

31462

1.99

194.72

5.9

4.9

g/l

35.1

35.0

0.55

4266

29047

(40768804) Tissue Pathology biopsy report

4064

27528

1.95

184.08

2.6

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

1466

6966

2.35

169.60

2.4

2.1

ug/g

149.4

154.2

0.11

1192

5392

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4995

37041

1.90

163.78

7.1

6.3

umol/l

11.2

11.9

3.71

4774

35141

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6549

53671

2.13

155.53

9.7

7.8

u/l

80.0

79.6

0.20

6252

50385

(40768797) Stomach Pathology biopsy report

1764

9667

2.05

139.74

1.3

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2821

18192

1.84

136.88

2.7

2.3

mg/l

3.2

3.0

3.15

2432

15437

(3044640) Blood type and Crossmatch panel - Blood

3289

22323

1.79

133.99

3.0

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4341

32347

1.73

124.14

4.6

4.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5051

39274

1.76

123.94

9.8

9.1

e9/l

4.2

0.05

4386

34130

(3013707) Erythrocyte sedimentation rate by Westergren method

6112

50292

1.87

123.52

4.9

4.2

mm/h

13.5

0.15

5699

46137

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3242

22298

1.75

123.24

2.9

2.6

u/l

58.7

58.6

0.02

3013

20498

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3729

26870

1.72

118.44

3.6

2.8

ug/l

141.9

154.0

1.21

3459

24466

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2602

17080

1.77

114.35

2.9

2.4

—

(3013115) Eosinophils [#/volume] in Blood

4559

34971

1.69

112.31

6.6

5.9

e9/l

0.2

0.62

3969

30352

(3006315) Basophils [#/volume] in Blood

4436

33868

1.68

110.46

6.4

5.7

e9/l

0.0

1.44

3822

28988

(3032080) INR in Blood by Coagulation assay

4114

30815

1.68

110.05

10.7

10.1

inr

1.3

0.22

912

8539

(3001604) Monocytes [#/volume] in Blood

4409

33674

1.68

109.04

6.4

5.7

e9/l

0.6

0.53

3794

28789

(3031040) Bacteria [#/volume] in Urine by Automated count

5601

45721

1.72

106.40

5.6

4.8

e6/l

759.9

1812.2

0.98

719

(3019198) Lymphocytes [#/volume] in Blood

4479

34517

1.66

105.50

6.5

5.8

e9/l

1.9

0.47

3899

30050

(3033658) Prothrombin time (PT) actual/Normal

2639

17807

1.71

102.71

5.0

4.0

87.9

87.1

0.76

2579

17369

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4036

30425

1.65

102.48

2.3

2.0

pmol/l

95.5

94.4

0.79

2276

15777

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1197

6418

2.01

97.30

2.7

2.4

u/l

35.1

45.7

0.71

1029

5466

(3014576) Chloride [Moles/volume] in Serum or Plasma

1602

9519

1.85

95.48

7.4

6.9

mmol/l

104.6

104.4

1.15

1568

9305

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7367

66251

2.19

93.03

21.9

16.1

mg/l

26.1

25.7

0.56

6368

53498

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4286

33329

1.60

91.78

7.1

6.1

mmol/l

1.2

3.02

3960

29988

(3013826) Glucose [Moles/volume] in Serum or Plasma

5149

42005

1.62

88.90

5.8

4.8

mmol/l

6.9

6.8

0.77

4904

39511

(3022948) Iron [Moles/volume] in Serum or Plasma

1839

11613

1.75

88.51

3.0

2.6

umol/l

12.1

12.6

2.03

1714

10683

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4608

36676

1.59

87.66

8.1

6.9

mmol/l

1.2

5.40

4059

30779

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1357

7855

1.87

87.05

2.8

2.7

umol/l

7.1

9.1

3.72

1212

6847

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1970

12818

1.71

84.56

1.3

1.2

u/ml

2.0

1.8

0.10

420

3289

(3037467) Urinalysis macro (dipstick) panel - Urine

5637

47267

1.63

84.52

5.4

4.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1779

11335

1.73

82.08

1.5

g/l

2.5

2.6

0.26

998

6657

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1619

10134

1.75

79.23

3.1

2.6

21.2

22.2

2.11

1421

8516

(40758558) Short blood count panel - Blood

2463

17228

1.62

78.72

7.0

6.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1692

10791

1.72

77.16

3.0

2.5

g/l

2.3

2.73

1586

9919

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

991

5386

1.96

76.22

1.7

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1894

12544

1.66

74.59

3.1

2.9

e6/l

1.0

1.4

0.81

1109

7354

(42870588) Differential panel, method unspecified - Blood

3161

23696

1.55

73.61

6.2

5.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2285

15987

1.60

71.57

4.4

3.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1169

6841

1.83

71.19

2.4

2.2

g/l

0.2

5.64

1088

6349

(3023368) Bacteria identified in Blood by Culture

2818

20723

1.55

70.85

4.9

4.4

—

(3019069) Monocytes/100 leukocytes in Blood

4008

31825

1.51

70.14

7.0

6.3

8.8

0.04

3751

29573

(3006504) Eosinophils/100 leukocytes in Blood

3990

31656

1.51

70.07

6.7

6.0

2.8

2.9

1.25

3733

29309

(3018010) Neutrophils/100 leukocytes in Blood

4016

31993

1.50

68.56

6.6

5.9

58.5

58.0

1.51

3734

29691

(3022096) Basophils/100 leukocytes in Blood

3881

30780

1.50

67.19

6.7

6.0

0.7

0.07

3630

28521

(3015736) pH of Urine

3349

25803

1.51

66.52

4.2

3.7

5.6

5.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1407

8854

1.71

66.22

2.4

2.5

1.8

0.03

1235

7776

(3002030) Lymphocytes/100 leukocytes in Blood

4051

32476

1.49

66.09

6.8

6.2

26.2

26.8

2.85

3763

29987

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2856

21349

1.52

65.18

3.5

3.3

u/l

32.1

35.5

1.25

2679

20117

(3018095) Leukocytes [#/volume] in Urine

3279

25243

1.50

64.89

4.4

3.9

e6/l

77.7

107.1

1.97

2385

18331

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1735

11610

1.63

64.21

3.3

3.1

e6/l

2.3

2.2

0.15

968

6465

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

767

4039

1.99

64.08

2.6

2.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3179

24408

1.50

63.24

3.7

3.4

mmol/l

2.4

0.35

2729

20962

(3019550) Sodium [Moles/volume] in Serum or Plasma

7512

69613

2.04

63.20

25.6

19.0

mmol/l

139.7

0.11

7401

67915

(3023103) Potassium [Moles/volume] in Serum or Plasma

7519

69760

2.04

62.11

25.8

19.1

mmol/l

4.0

1.85

7402

67944

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4930

41397

1.48

61.95

3.9

3.2

u/l

55.4

53.4

0.65

4616

37878

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1966

13673

1.58

61.51

3.5

3.1

mmol/l

2.5

0.44

1723

11930

(3030467) Casts [#/volume] in Urine by Automated count

2707

20312

1.50

59.22

3.7

3.3

e6/l

0.5

0.05

2053

15467

(3002256) Pathology report gross observation

1401

9095

1.65

57.79

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6717

60580

1.63

57.79

5.4

4.8

mu/l

1.9

2.1

2.28

6169

54580

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3004

23171

1.47

56.53

3.3

3.1

ng/l

1540.0

1567.5

0.13

2607

20111

(3009261) Glucose [Presence] in Urine by Test strip

4098

33538

1.45

56.37

4.5

3.9

estimate

0.0

0.15

552

6043

(3021960) Folate [Moles/volume] in Serum or Plasma

2385

17608

1.50

55.69

1.7

1.6

nmol/l

20.4

20.2

0.19

2073

14917

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

553

2741

2.09

54.31

3.5

3.4

u/ml

182.3

2545.4

1.55

470

2340

(36304419) Bacteria [Presence] in Urine

2591

19533

1.48

54.22

3.7

3.2

—

(3035350) Ketones [Presence] in Urine by Test strip

4036

33084

1.44

54.13

4.4

3.9

estimate

0.0

0.50

547

6149

(3019309) Folate [Moles/volume] in Red Blood Cells

2057

14798

1.52

54.07

1.8

nmol/l

1101.4

1169.1

2.55

1563

11044

(3002582) Erythrocytes [#/volume] in Urine

2866

22097

1.46

53.16

3.8

3.4

e6/l

54.7

93.2

1.49

2219

17145

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7520

70288

1.93

52.93

14.3

11.2

u/l

25.5

26.0

1.34

7324

67472

(3021601) Nitrite [Presence] in Urine by Test strip

4034

33151

1.43

52.85

5.9

5.2

estimate

0.0

0.38

575

6216

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5689

49829

1.47

52.60

4.3

4.0

pmol/l

15.0

0.43

5164

44609

(3014111) Lactate [Moles/volume] in Serum or Plasma

1064

6583

1.71

52.24

6.8

6.7

mmol/l

1.3

1.4

0.84

1018

6339

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6875

62763

1.62

51.65

19.7

15.3

ml/min/173m2

75.5

76.1

1.46

5856

52150

(3003396) Base excess in Arterial blood by calculation

1352

8929

1.62

51.45

7.0

mmol/l

0.9

1.1

0.86

1068

6948

(3014765) Yersinia sp identified in Stool by Organism specific culture

411

1852

2.28

51.22

1.3

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1355

8965

1.61

51.15

7.0

kpa

12.0

12.1

0.29

1286

8522

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1355

8969

1.61

51.05

7.0

kpa

5.2

5.1

2.24

1288

8535

(42529406) Shigella sp [Presence] in Stool by Culture

411

1861

2.27

50.63

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

407

1837

2.28

50.52

1.3

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3473

27932

1.42

50.42

2.5

2.2

nmol/l

78.6

79.0

0.44

3104

24637

(40761511) CBC panel - Blood by Automated count

7324

68055

1.77

50.41

20.7

15.4

—

(3023520) Reticulocytes [#/volume] in Blood

1077

6747

1.69

50.36

2.5

2.6

e9/l

69.2

69.1

0.03

823

5151

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

671

3671

1.90

49.63

1.6

1.7

g/l

1.6

0.13

579

3119

(3026493) Urate [Moles/volume] in Serum or Plasma

2492

18989

1.45

47.96

3.0

2.8

umol/l

3288.9

5300.6

2.01

2185

16179

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3498

28360

1.41

47.57

4.4

3.9

ng/l

43.5

76.5

1.24

2622

21047

(3000991) Gas panel - Venous blood

1002

6248

1.69

47.49

8.5

8.0

—

(3016502) Oxygen saturation in Arterial blood

1229

8074

1.62

47.44

7.2

7.3

95.7

95.5

0.31

1188

7753

(3000570) Elastase.pancreatic [Mass/mass] in Stool

442

2119

2.15

47.25

1.5

1.4

ug/g

272.2

266.3

0.23

269

1278

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6839

62687

1.57

46.77

7.2

6.3

mmol/mol

40.8

40.5

1.53

6367

57299

(3042936) Bacteria identified in Isolate by Culture

1488

10275

1.55

46.21

2.1

2.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1138

7391

1.63

45.91

7.6

7.8

g/l

119.3

120.6

1.44

1098

7110

(3026008) Bacteria identified in Urine by Culture

2811

22051

1.42

45.57

3.5

3.3

—

(3018418) pH of Serum or Plasma

2777

21739

1.42

45.54

4.9

4.1

7.4

0.06

387

4164

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1314

8855

1.58

45.37

4.0

4.2

u/l

239.6

247.0

1.10

1232

8326

(3044889) 12 lead EKG panel

5521

48764

1.41

43.44

4.6

4.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

6379

57968

1.47

41.90

24.1

17.3

38.6

39.2

4.88

4276

37961

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1393

9701

1.53

41.08

6.4

5.8

mmol/l

1.0

0.35

1299

8977

(3007461) Platelets [#/volume] in Blood

7633

72403

1.89

40.89

33.2

23.7

e9/l

245.1

244.3

0.50

7497

70373

(3004716) Salmonella sp identified in Stool by Organism specific culture

493

2593

1.96

40.84

1.4

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1505

10668

1.50

40.77

32.3

27.5

inr

1.5

1.4

1.16

171

1465

(3000963) Hemoglobin [Mass/volume] in Blood

7635

72438

1.89

40.73

33.4

23.9

g/l

132.1

134.5

34.82

7562

71269

(3035941) MCH [Entitic mass]

7633

72422

1.88

40.58

33.1

23.6

30.4

3.50

7556

71241

(3024731) MCV [Entitic volume]

7633

72424

1.88

40.54

33.1

23.7

91.5

0.22

7558

71244

(3026361) Erythrocytes [#/volume] in Blood

7633

72428

1.88

40.48

33.2

23.7

e12/l

4.4

15.54

7475

70138

(3010813) Leukocytes [#/volume] in Blood

7634

72442

1.88

40.45

33.3

23.8

e9/l

6.9

6.8

2.20

7479

70134

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

685

4030

1.76

39.73

8.6

8.9

mmol/l

24.3

0.06

633

3735

(40761535) Cells panel - Urine sediment

963

6209

1.62

39.62

4.0

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2823

22556

1.39

39.59

2.2

u/l

188.2

220.9

1.13

2655

21028

(3025941) Bacteria identified in Stool by Culture

606

3459

1.81

38.91

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1654

12104

1.46

37.82

3.3

3.2

mmol/l

0.8

1.12

1547

11262

(3019150) Specific gravity of Urine by Refractometry

1942

14655

1.43

37.59

5.2

4.4

kg/l

1.0

0.51

297

2241

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7013

65313

1.54

37.51

5.7

5.0

mmol/l

6.1

6.0

2.87

6462

58733

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1669

12295

1.45

36.70

2.0

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

2040

15586

1.41

36.67

2.8

2.7

e6/l

4.4

4.9

1.50

1746

13643

(36660697) Celiac disease serology panel - Serum

751

4631

1.68

36.65

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4054

34552

1.35

36.61

2.7

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1937

14713

1.42

35.86

1.9

1.7

mg/l

1.2

1.3

1.20

1532

11421

(3026782) Osmolality of Urine

1905

14440

1.42

35.65

3.1

2.9

mosm/kgh2o

545.2

549.7

0.40

1588

12289

(3003327) Ova and parasites identified in Stool by Light microscopy

367

1833

2.05

35.14

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

493

2735

1.85

34.65

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1020

6901

1.55

33.81

8.2

7.1

mmol/l

10.9

10.6

0.61

966

6559

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7123

66931

1.52

32.58

5.8

5.3

mmol/l

2.6

2.7

3.37

6626

60835

(3003338) MCHC [Mass/volume]

5889

53541

1.36

32.25

30.0

21.0

g/l

331.0

331.9

12.55

5845

53108

(3013139) Helicobacter pylori Ag [Presence] in Stool

696

4353

1.65

32.02

1.3

1.2

—

(3021589) Normoblasts [#/volume] in Blood

3504

29617

1.32

31.72

10.9

10.2

e9/l

0.0

0.86

2861

24188

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

855

5640

1.58

31.58

4.4

3.8

ng/l

100.5

94.7

0.99

744

4795

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1882

14549

1.38

30.61

4.4

4.0

ng/l

391.2

490.6

0.42

1560

12110

(3037522) Nuclear Ab [Titer] in Serum

1179

8401

1.47

30.22

1.3

titre

536.0

506.1

0.22

247

1798

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1184

8472

1.47

29.66

1.9

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

410

2261

1.86

29.32

1.7

1.6

—

(3009508) Creatinine [Moles/volume] in Urine

2813

23232

1.32

29.30

3.3

3.2

mmol/l

7.5

7.4

0.78

2375

19215

(3020682) Albumin/Creatinine [Ratio] in Urine

2883

23894

1.32

29.28

4.2

4.0

mg/mmol

10.2

9.2

0.53

1914

15026

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

712

4595

1.60

28.76

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

1125

8034

1.46

28.37

1.5

1.4

—

(3012544) pH of Venous blood

1035

7278

1.48

28.22

4.6

3.8

7.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1173

8457

1.45

28.12

2.0

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1002

7021

1.49

27.78

4.6

3.8

kpa

5.9

5.8

0.84

979

6814

(4010399)

768

5097

1.56

27.46

1.5

1.4

—

(3012516) Albumin [Mass/volume] in Urine

2737

22687

1.31

27.24

3.4

3.3

mg/l

549.5

385.3

0.85

1809

14370

(3002032) Base excess in Venous blood by calculation

995

6991

1.48

27.18

4.7

3.8

mmol/l

1.9

0.01

821

5666

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

993

6979

1.48

27.08

2.4

ug/l

5.6

7.3

2.55

847

6035

(3007853) Bacteria identified in Skin by Aerobe culture

1142

8252

1.45

26.96

1.9

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1354

10100

1.41

26.78

1.3

1.2

u/ml

8.0

14.1

3.34

467

3716

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6940

65377

1.42

26.42

5.2

4.7

mmol/l

4.5

4.6

3.92

6462

59715

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

467

2775

1.72

25.94

2.9

u/ml

0.3

1.39

242

1587

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6887

64840

1.41

25.86

5.1

4.7

mmol/l

1.4

1.5

1.98

6368

58802

(3020961) Endomysium IgA Ab [Titer] in Serum

437

2551

1.75

25.85

1.1

titre

491.7

193.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

557

3474

1.65

25.78

5.1

4.0

mmol/l

24.0

24.2

0.50

504

3108

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1418

10730

1.39

25.66

1.3

iu/ml

30.9

37.1

0.90

426

3289

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

652

4242

1.58

25.36

9.3

9.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

840

5779

1.51

25.36

2.8

2.7

ml/min/173m2

61.8

62.7

0.28

370

2334

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6687

62709

1.37

25.21

4.6

4.2

mmol/l

1.3

4.85

6134

56340

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1518

11647

1.37

25.18

2.2

2.0

30.1

30.0

0.34

1483

11294

(4035726)

924

6496

1.48

25.05

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

848

5903

1.49

24.11

1.7

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1244

9332

1.39

23.52

9.9

7.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1015

7353

1.43

23.41

1.8

1.6

—

(3019060) Gas panel - Arterial blood

768

5273

1.50

23.33

4.5

4.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

732

4983

1.52

23.16

2.6

2.7

g/l

10.5

10.6

0.06

670

4535

(3052851) Hemolysis interference index of Serum or Plasma

380

2202

1.76

23.06

3.8

3.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

823

5744

1.48

23.06

3.6

3.1

kpa

4.5

0.44

797

5550

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

384

2237

1.75

22.88

1.3

—

(3000492) Spirometry study

831

5839

1.47

22.48

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

5779

53342

1.29

22.46

26.9

19.6

14.0

13.8

16.65

5696

52140

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

897

6418

1.45

22.05

1.6

1.5

—

(3013512) EKG study

2600

21871

1.28

21.85

4.7

4.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

922

6650

1.44

21.69

2.4

2.6

g/l

65.9

66.1

0.36

845

5974

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

320

1827

1.78

20.45

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3184

27602

1.25

20.33

5.6

5.3

ug/l

3.0

3.6

0.97

2880

24615

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

641

4366

1.51

20.16

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

783

5564

1.45

19.88

2.3

2.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

822

5896

1.44

19.85

2.4

2.3

nmol/l

374.4

374.5

0.01

749

5401

(3028026) IgM [Mass/volume] in Serum or Plasma

583

3912

1.53

19.67

2.0

1.8

g/l

1.6

1.4

0.72

534

3525

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

305

2.94

19.66

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

637

4385

1.49

19.01

7.9

7.1

mmol/l

24.8

0.05

629

4352

(3034770) Mitochondria Ab [Titer] in Serum

302

1742

1.76

18.66

1.2

titre

1484.5

876.7

0.93

(3007566) Smooth muscle Ab [Titer] in Serum

299

1739

1.75

17.96

1.2

titre

113.9

171.1

0.69

146

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2917

25335

1.24

17.51

5.0

4.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

379

2382

1.62

17.00

1.1

u/ml

1.3

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

429

2778

1.57

16.97

4.0

4.1

mmol/l

1.3

1.4

0.72

423

2736

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2567

22063

1.24

16.81

4.9

4.6

21.7

22.0

0.45

1364

11465

(3043409) Potassium [Moles/volume] in Arterial blood

376

2367

1.62

16.75

4.1

4.3

mmol/l

3.9

0.45

359

2219

(3008152) Bicarbonate [Moles/volume] in Arterial blood

694

4997

1.43

16.32

7.0

mmol/l

24.5

24.6

0.16

649

4651

(3003694) ABO and Rh group [Type] in Blood

2035

17136

1.25

15.86

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

677

4882

1.42

15.78

4.3

3.6

kpa

5.2

5.1

0.04

632

4490

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1026

7923

1.34

15.67

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

387

2.50

15.57

1.4

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

850

6397

1.37

15.35

1.9

1.7

1.6

1.5

1.83

714

5452

(3009343) pH of Capillary blood

667

4822

1.42

15.32

4.2

3.6

7.4

0.06

624

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

391

2.47

15.25

1.4

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

643

4637

1.42

14.97

4.2

3.6

mmol/l

1.6

1.9

0.75

478

3447

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

268

1596

1.70

14.84

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

268

1596

1.70

14.84

1.4

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2141

18248

1.24

14.74

5.2

4.3

estimate

0.0

0.01

549

5920

(3038177) Helicobacter pylori Ab [Presence] in Serum

172

898

1.94

14.70

1.4

1.3

—

(3020891) Body temperature

453

3099

1.49

13.93

5.0

4.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

3165

1.48

13.92

2.1

2.3

g/l

3.7

3.8

0.44

335

2236

(40760892) CBC W Ordered Manual Differential panel - Blood

1675

13977

1.25

13.86

5.1

4.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

3171

1.48

13.79

2.1

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

400

2672

1.52

13.79

2.4

2.2

ug/l

357.2

684.6

2.15

380

2528

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

3172

1.48

13.77

2.2

2.3

g/l

7.5

7.4

0.11

348

2329

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

165

869

1.92

13.77

3.7

3.3

nmol/l

12.8

12.6

0.01

158

850

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

434

2955

1.50

13.66

2.1

2.3

g/l

10.2

0.01

369

2458

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

474

3286

1.47

13.63

2.0

1.9

ug/l

2.4

2.2

0.09

425

2869

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

436

2993

1.48

13.18

4.6

3.9

mmol/l

24.6

24.9

0.94

398

2732

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

495

3485

1.45

13.14

3.4

2.7

0.7

0.00

473

3336

(3022313) Gas panel - Capillary blood

494

3482

1.45

13.03

4.4

3.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

430

2951

1.48

13.02

2.2

2.3

g/l

3.1

0.61

342

2275

(3037121) Protein [Mass/volume] in Urine

373

2504

1.51

12.58

3.2

3.0

g/l

0.3

0.04

169

1029

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

328

2142

1.55

12.56

2.3

g/l

0.0

0.00

305

1957

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

394

2680

1.49

12.48

2.5

2.3

g/l

0.9

1.0

0.06

346

2265

(3045414) Leukocytes [Presence] in Urine

449

3135

1.46

12.46

2.0

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

180

1011

1.80

12.31

1.6

1.5

g/l

0.8

0.12

147

755

(3004119) Hemoglobin [Mass/volume] in Venous blood

625

4643

1.37

12.19

3.8

3.4

g/l

125.0

128.3

3.10

607

4532

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

160

872

1.85

12.07

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

330

2183

1.53

11.94

2.3

2.2

g/l

0.0

0.50

306

1967

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

348

2338

1.51

11.72

2.4

2.2

g/l

0.0

0.97

324

2115

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

294

1906

1.56

11.65

2.5

2.3

g/l

3.6

0.09

283

1808

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

157

861

1.84

11.63

1.1

g/l

1.6

1.5

0.05

140

767

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

256

1610

1.61

11.55

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

247

1541

1.62

11.52

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

171

966

1.79

11.50

1.5

1.3

nmol/l

0.7

2.3

0.68

163

928

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

165

924

1.80

11.43

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

179

1028

1.76

11.38

1.2

—

(3019225) pH of Specimen

961

7669

1.29

11.38

5.1

4.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

360

2453

1.49

11.33

2.2

2.1

g/l

37.1

37.4

0.41

320

2073

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

570

4228

1.37

11.23

2.5

2.4

au/ml

29.5

24.1

0.26

166

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

397

2768

1.46

11.12

2.6

2.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

142

768

1.86

11.01

3.0

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1833

15770

1.21

10.95

3.4

3.2

ug/l

0.8

0.04

1357

11093

(3015171) Extractable nuclear Ab [Units/volume] in Serum

351

2397

1.49

10.94

1.2

u/ml

0.3

1.1

2.77

235

(3024522) Salmonella sp identified in Specimen by Organism specific culture

164

936

1.77

10.68

1.5

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

505

3703

1.39

10.68

3.0

3.3

pmol/l

4.4

0.46

445

3247

(3030981) Hyaline casts [#/volume] in Urine by Automated count

538

3990

1.37

10.61

2.8

2.9

e6/l

0.2

0.3

2.77

524

3905

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

165

951

1.75

10.40

1.5

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

518

3838

1.37

10.28

1.4

1.3

au/ml

39.3

55.5

0.62

169

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

167

970

1.74

10.25

1.5

1.3

nmol/l

0.1

0.3

1.35

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

378

2653

1.45

10.25

2.9

3.3

mg/l

67.9

45.6

0.34

328

2154

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

254

1644

1.56

10.19

3.4

3.3

u/ml

218.0

651.3

1.53

215

1499

(44816559) Phosphatidylethanol [Mass/volume] in Blood

171

1004

1.72

10.11

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

377

2655

1.44

10.04

2.9

3.3

mg/l

179.1

80.9

0.36

328

2156

(3049717) Cytology report of Urine Cyto stain

443

3212

1.40

10.02

2.9

2.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

160

926

1.74

9.96

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

139

772

1.81

9.95

4.4

3.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

512

3821

1.36

9.72

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

236

1520

1.57

9.69

1.1

u/ml

7.2

9.9

0.27

136

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

118

628

1.89

9.68

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

118

628

1.89

9.68

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

118

628

1.89

9.68

1.6

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

366

2582

1.44

9.67

2.9

3.2

ratio

6.7

3.0

0.39

192

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

486

2.01

9.49

1.3

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

170

1017

1.69

9.41

6.5

6.4

mg/l

12.4

12.0

0.55

152

930

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

158

927

1.72

9.40

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

158

930

1.71

9.29

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

388

2787

1.41

9.29

1.9

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

479

3564

1.37

9.28

1.3

u/ml

150.3

241.9

4.19

435

3259

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

229

1481

1.56

9.26

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

635

4928

1.31

9.25

2.3

2.1

nmol/l

12.1

12.4

0.31

551

4294

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

823

6607

1.27

9.24

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

404

2931

1.40

9.13

2.0

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

185

1141

1.64

9.12

1.3

—

(3024928) Oxygen saturation in Venous blood

237

1550

1.54

9.12

3.6

3.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

100

515

1.95

9.07

1.2

titre

431.4

147.2

1.08

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

281

1909

1.49

9.04

1.5

1.6

iu/ml

0.7

7.7

1.09

444

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

429

2.04

8.92

1.5

1.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

261

1755

1.50

8.84

2.4

2.3

194.9

201.7

0.61

249

1672

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

160

966

1.67

8.60

3.1

2.1

mg/l

24.1

27.0

0.24

240

(3023183) Ammonium ion [Moles/volume] in Plasma

234

1550

1.52

8.52

3.3

2.6

umol/l

33.0

34.0

0.26

185

1300

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

192

1218

1.59

8.47

1.9

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1817

15945

1.18

8.39

1.7

pmol/l

19044893.7

31336483.8

0.61

1507

13001

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

144

852

1.70

8.36

1.5

1.3

nmol/l

—

(4211845)

366

2.09

8.33

4.6

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

429

3193

1.36

8.32

2.1

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

253

1713

1.49

8.31

1.2

u/ml

21.2

43.2

—

(3006462) Nitrate [Presence] in Urine

334

2.14

8.27

4.7

3.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

197

1269

1.57

8.16

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

346

2500

1.40

8.05

1.8

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

360

2.07

7.92

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

360

2.07

7.92

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

157

971

1.63

7.73

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

275

1928

1.44

7.59

2.3

2.0

91.5

89.0

0.96

266

1807

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

400

2992

1.35

7.54

2.8

4.0

u/ml

47.7

67.4

1.19

385

2871

(3037756) Immunofixation for Serum or Plasma

255

1766

1.46

7.52

1.4

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

245

1685

1.47

7.49

3.2

3.1

nmol/l

0.8

0.59

186

1294

(3045424) Erythrocytes [Presence] in Urine

182

1182

1.55

7.31

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2049

18325

1.16

7.28

1.7

mmol/l

1.4

0.93

1751

15135

(3027273) Bicarbonate [Moles/volume] in Venous blood

484

3757

1.31

7.08

4.0

3.5

mmol/l

25.2

0.19

476

3642

(40768443) Skin Pathology biopsy report

429

3276

1.33

7.06

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

161

1026

1.58

7.04

1.5

e6/l

1494.2

2262.6

1.24

106

744

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

748

1.68

7.03

3.2

3.6

—

(3036489) Thrombin time

331

2433

1.38

6.99

2.2

1.9

23.3

21.7

1.53

300

2150

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

267

1894

1.42

6.95

1.4

1.5

g/l

0.2

0.12

252

1783

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.30

6.95

2.7

2.6

u/field

0.4

0.5

0.25

(40760888) Immunoglobulin light chains.free panel - Serum

279

1995

1.41

6.94

3.0

3.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

393

1.94

6.92

3.3

1.7

nmol/l

17.6

16.2

0.84

361

(3011985) Renin [Units/volume] in Plasma

148

932

1.60

6.82

1.4

mu/l

42.8

58.2

0.90

134

828

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

123

741

1.67

6.76

1.9

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

117

697

1.69

6.71

2.0

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

220

1519

1.46

6.64

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

179

1187

1.52

6.59

1.2

u/ml

34.3

43.0

0.33

124

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1069

9140

1.20

6.55

4.7

4.8

33.0

32.9

0.13

758

6045

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

371

2808

1.34

6.51

1.9

1.8

u/l

39.2

38.6

0.22

321

2411

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

125

771

1.63

6.30

1.2

u/l

58.7

63.1

0.20

505

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

173

1152

1.51

6.26

2.0

1.9

pmol/l

187.9

199.3

0.82

159

1082

(40768441) Liver Pathology biopsy report

487

1.79

6.24

1.6

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

826

6930

1.21

6.19

2.7

2.9

ng/l

246.9

215.1

1.08

752

6353

(3009214) Lutropin [Units/volume] in Serum or Plasma

174

1164

1.51

6.17

1.4

1.3

u/l

12.0

11.1

0.32

142

943

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

266

1932

1.39

6.09

1.5

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

253

1823

1.40

6.07

1.8

1.6

e6/l

19455.3

14282.1

0.65

183

1310

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

269

1959

1.39

6.07

1.5

g/l

1.2

0.01

255

1846

(21494434) Karyotype in Bone marrow

113

687

1.65

6.05

1.2

—

(3042733) HLA Ab [Presence] in Serum

177

2.32

5.97

5.1

4.9

—

(3020491) Glucose [Moles/volume] in Blood

488

1.77

5.91

2.0

2.1

mmol/l

7.5

7.0

0.65

324

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

224

1588

1.42

5.91

1.3

u/ml

7.4

5.0

0.25

165

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

226

1605

1.42

5.91

1.3

u/ml

8.1

7.0

0.11

265

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

152

998

1.53

5.90

1.2

u/ml

337.2

282.7

0.84

102

620

(3045788) Cell count panel - Pleural fluid

125

785

1.60

5.89

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

205

1434

1.44

5.83

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

418

1.83

5.80

1.2

u/l

29.3

21.6

0.48

351

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

162

1083

1.51

5.79

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

115

711

1.63

5.78

1.3

1.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

323

2447

1.33

5.68

1.6

titre

156.7

282.9

—

118

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

222

1584

1.41

5.67

1.9

1.8

nmol/l

42.3

43.4

0.32

215

1518

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

195

1360

1.44

5.64

5.3

5.1

iu/ml

465.3

2287.0

0.80

205

(3051651) Icteric interference index of Serum or Plasma

422

1.81

5.64

5.8

3.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

430

1.80

5.61

1.2

u/l

106.0

85.5

0.73

369

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

237

1714

1.39

5.60

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

422

3323

1.28

5.60

4.9

5.1

1.7

1.6

0.27

393

3111

(40757494) Bilirubin.total [Moles/volume] in Blood

410

1.81

5.54

1.9

2.3

umol/l

14.4

27.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

315

2391

1.33

5.48

1.6

1.5

—

(4094501)

261

1926

1.37

5.47

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

174

1196

1.46

5.45

1.6

1.4

u/ml

11.3

16.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

279

1.98

5.38

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

174

1200

1.46

5.36

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

393

1.81

5.34

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

393

1.81

5.34

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

171

1177

1.46

5.33

1.5

g/l

31.9

31.8

0.04

146

1056

(3014148) Varicella zoster virus Ab [Titer] in Serum

529

1.69

5.24

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

432

1.77

5.24

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

432

1.77

5.24

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

190

1339

1.43

5.23

1.3

1.2

u/ml

10.2

4.1

0.36

100

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

433

1.76

5.21

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

133

874

1.53

5.20

1.3

pmol/l

241.6

307.1

0.96

112

656

(40759836) Histone Ab [Presence] in Serum by Immunoblot

426

1.77

5.19

1.2

1.1

—

(3035880) pH of Pleural fluid

471

1.73

5.17

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

249

2.01

5.16

35.7

32.1

ug/l

7.0

7.4

0.82

220

(3028308) Erythrocytes [#/volume] in Pleural fluid

140

932

1.51

5.15

1.5

e6/l

52302.6

63262.2

0.23

549

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

427

1.76

5.15

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

427

1.76

5.15

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

579

1.65

5.10

1.7

2.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.84

5.07

1.2

nmol/l

8.8

391185.3

0.72

(3007930) Methemoglobin/Hemoglobin.total in Blood

413

3289

1.27

5.03

5.0

5.2

0.9

0.74

386

3081

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.90

5.02

1.5

1.7

umol/l

51.8

41.6

0.95

(1761482) Bacteria [#/volume] in Urine by Culture

270

2032

1.34

5.01

4.6

4.4

—

(3022621) pH of Urine by Test strip

564

4656

1.23

4.99

3.5

3.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

280

1.93

4.99

2.7

2.6

—

30.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

191

1365

1.41

4.89

1.3

1.2

—

14.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

100

2.61

4.88

10.4

12.8

mmol/l

4.9

5.4

0.83

100

(21494890) Protein electrophoresis panel - 24 hour Urine

129

855

1.52

4.87

1.8

2.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

153

1051

1.46

4.85

1.6

1.4

u/ml

128.9

123.7

0.13

233

(3006270) Folate [Moles/volume] in Blood

100

626

1.60

4.85

1.4

1.2

nmol/l

326.0

344.8

0.40

499

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

150

1027

1.47

4.84

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

348

1.82

4.81

1.3

1.2

u/l

252.5

318.9

0.45

319

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

205

1488

1.39

4.80

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

108

691

1.57

4.79

1.1

u/ml

8.6

3.4

0.46

255

(3015235) Bicarbonate [Moles/volume] in Capillary blood

265

2009

1.33

4.71

3.4

3.1

mmol/l

24.4

24.9

0.73

235

1746

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

531

1.65

4.68

1.5

1.4

u/l

35.5

33.6

0.18

432

(3003181) Sodium [Moles/volume] in Urine

187

1343

1.40

4.67

1.4

1.3

mmol/l

58.0

62.5

0.93

146

1087

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

524

1.65

4.66

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

465

3791

1.24

4.65

4.0

3.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

150

1038

1.45

4.60

2.5

u/ml

2076.0

1828.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

376

1.76

4.57

2.0

1.8

u/field

1.2

2.2

1.51

259

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

536

1.63

4.53

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

101

647

1.57

4.48

1.5

1.3

g/l

2.7

3.0

0.81

451

(3027135) IgG subclass 1 [Mass/volume] in Serum

101

647

1.57

4.48

1.5

1.3

g/l

6.9

6.8

0.10

450

(3024139) IgG subclass 3 [Mass/volume] in Serum

101

647

1.57

4.48

1.5

1.3

g/l

0.4

0.48

452

(3044927) Protein electrophoresis panel - Urine

125

842

1.49

4.41

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

267

2047

1.31

4.41

1.5

1.4

—

(44813793)

374

1.74

4.37

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

113

749

1.52

4.32

1.1

1.2

u/ml

8.3

50.0

—

(3024471) HLA-A [Type]

184

2.07

4.29

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

101

2.48

4.28

1.3

1.8

—

(40768806) Pleura Pathology biopsy report

132

905

1.47

4.28

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

355

1.75

4.25

1.3

1.2

—

(44806118)

116

776

1.50

4.25

1.5

1.4

—

(44790047)

116

776

1.50

4.25

1.5

1.4

—

(44790049)

116

776

1.50

4.25

1.5

1.4

—

(44790048)

116

776

1.50

4.25

1.5

1.4

—

(3024932) HLA-DR beta [Type]

178

2.08

4.25

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

291

1.83

4.18

1.5

1.3

—

(3016879) Cocaine [Presence] in Urine

125

853

1.47

4.16

1.4

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

186

1365

1.37

4.13

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

111

741

1.50

4.12

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

167

2.10

4.11

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

230

1745

1.33

4.11

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

114

771

1.49

3.99

1.4

mmol/l

6.5

6.3

0.28

104

705

(4062490)

650

1.53

3.98

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

132

919

1.44

3.98

1.3

1.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

235

1799

1.32

3.96

2.9

2.8

mg/l

1.7

0.39

219

1630

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

611

1.54

3.96

1.8

2.1

u/field

2.4

2.0

0.23

230

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

192

1427

1.35

3.96

1.2

1.1

—

(3036603) Volume of Urine

486

1.61

3.93

1.9

1.6

1870.4

1909.9

0.10

131

(3000764) Benzodiazepines [Presence] in Urine

131

914

1.44

3.91

1.4

1.9

—

(3011648) Oxygen content in Venous blood

558

1.57

3.89

2.0

10.9

11.0

0.07

558

(3006922) Hepatitis E virus Ab [Presence] in Serum

403

1.67

3.88

1.1

—

(3028300) Cannabinoids [Presence] in Urine

132

924

1.44

3.88

1.4

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

178

2.03

3.87

1.1

—

(1002224) Polysomnography panel

270

2114

1.29

3.86

1.1

—

(3021788) Differential panel - Synovial fluid

179

1326

1.36

3.78

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

230

1769

1.31

3.77

2.7

2.2

g/l

126.6

127.6

0.27

156

1276

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

114

2.28

3.77

2.3

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

128

897

1.43

3.75

3.7

4.7

umol/l

345.1

352.0

0.20

101

765

(43055442) Apixaban [Mass/volume] in Serum or Plasma

127

2.21

3.75

1.9

1.5

ug/l

83.2

113.7

1.21

106

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

469

1.60

3.75

1.0

mg/l

300.0

287.9

0.40

421

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

597

1.53

3.70

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

424

1.63

3.70

1.5

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

357

1.69

3.64

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

1925

20763

0.90

3.61

3.2

3.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

626

1.51

3.58

1.3

u/l

12.7

13.1

0.06

568

(3018133) Calcium [Moles/volume] in Urine

2.50

3.54

1.4

1.6

mmol/l

3.1

2.6

0.48

(3035637) Corticotropin [Mass/volume] in Plasma

119

833

1.43

3.53

1.4

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

120

842

1.43

3.52

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

293

1.75

3.52

3.1

2.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

173

1291

1.35

3.52

1.6

1.7

—

(3027944) Amphetamines [Presence] in Urine

127

901

1.42

3.51

1.3

1.9

—

(3038515) Glucose [Moles/volume] in Venous blood

214

1649

1.31

3.49

4.1

3.5

mmol/l

7.5

7.7

0.49

207

1612

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

518

1.55

3.48

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

303

1.72

3.42

1.7

1.5

ug/l

11.7

8.7

0.38

266

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

457

1.58

3.42

1.6

1.5

u/l

4.2

6.9

1.05

207

(3044941) Cell count panel - Synovial fluid

153

1127

1.36

3.39

1.7

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

289

1.73

3.39

4.8

4.5

mg/l

59.7

64.3

0.28

203

(3008037) Lactate [Moles/volume] in Venous blood

224

1744

1.29

3.39

4.0

3.3

mmol/l

1.6

1.7

1.14

217

1700

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

522

1.54

3.37

1.1

1.2

—

(3017704) Immunofixation for Urine

452

1.58

3.33

1.3

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

100

688

1.46

3.28

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

1272

1.34

3.27

1.3

u/l

46.6

38.8

0.23

145

1100

(3034274) Bile acid [Moles/volume] in Serum --fasting

308

1.69

3.25

1.3

1.6

umol/l

8.2

13.3

0.63

211

(3047181) Lactate [Moles/volume] in Blood

302

2454

1.24

3.22

5.7

6.2

mmol/l

1.3

0.18

257

2169

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

279

1.72

3.21

2.0

2.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.27

3.18

1.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

1769

1.28

3.18

1.6

—

(3023410) Appearance of Cerebral spinal fluid

579

1.49

3.16

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

217

1703

1.28

3.12

3.3

2.9

kpa

8.0

7.9

0.40

206

1564

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.80

3.08

1.4

ml/s/173m2

0.8

0.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

858

1.39

3.05

1.2

u/ml

4.1

4.2

0.02

355

(3017732) Neutrophils [#/volume] in Blood

541

4670

1.17

3.04

3.0

3.1

e9/l

4.2

4.1

0.49

403

3448

(3012441) Differential panel - Pleural fluid

124

902

1.38

3.02

1.6

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

448

1.54

3.01

1.5

umol/l

13.5

13.8

0.12

421

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

401

1.58

3.00

1.1

nmol/l

0.2

10.6

1.91

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

394

1.58

2.97

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

539

1.49

2.95

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

605

1.46

2.94

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

121

881

1.38

2.94

1.2

u/ml

3.7

4.2

0.08

268

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

216

1709

1.27

2.93

1.6

—

(3008898) HLA-B27 [Presence]

200

1568

1.28

2.92

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

224

1782

1.26

2.91

2.2

1.9

mg/l

12.9

11.9

0.86

208

1628

(3000060) B lymphocytes [#/volume] in Blood

128

2.03

2.90

1.5

1.9

e6/l

1370.6

924.2

0.12

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

542

1.48

2.88

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

266

1.70

2.87

2.4

2.2

e6/l

665.4

3857.6

0.54

179

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

650

1.44

2.86

2.2

1.9

u/l

439.8

2211.3

2.57

250

(3016650) Hepatitis A virus Ab [Presence] in Serum

131

972

1.35

2.84

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

154

1171

1.32

2.83

2.0

1.7

mu/l

279.6

309.6

0.70

140

1072

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

407

1.55

2.83

1.3

u/ml

2.2

1.3

0.35

207

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

136

1017

1.34

2.81

1.2

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.23

2.79

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

126

934

1.35

2.76

1.6

1.5

—

(3039000) Anion gap in Blood

224

1796

1.25

2.74

6.3

6.9

mmol/l

11.4

11.2

0.31

196

1607

(3018572) Chloride [Moles/volume] in Blood

224

1796

1.25

2.74

6.3

7.0

mmol/l

104.7

105.1

0.63

196

1607

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

838

7516

1.13

2.74

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

443

1.52

2.73

2.0

2.4

e6/l

558.7

605.2

0.22

195

(3035320) C reactive protein [Mass/volume] in Body fluid

477

1.49

2.69

2.1

2.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

182

1.82

2.68

1.5

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

176

1375

1.29

2.67

1.2

mmol/l

3.7

3.9

0.97

163

1280

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.21

2.67

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.21

2.67

1.1

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

205

1.76

2.64

1.6

2.0

11.9

10.2

0.23

184

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

359

1.56

2.63

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.39

2.62

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.66

2.62

1.5

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

425

1.51

2.57

1.7

2.4

e6/l

515.4

511.3

0.02

357

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

196

1562

1.26

2.55

1.3

mg/l

519.8

543.9

0.37

181

1473

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

230

1.70

2.54

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

1316

1.28

2.52

1.9

1.6

nmol/l

0.9

0.8

0.50

142

1089

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

379

1.53

2.52

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

300

1.60

2.52

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

202

1619

1.25

2.51

2.5

2.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

380

1.53

2.49

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

172

1.81

2.49

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

438

1.49

2.46

1.8

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.38

2.45

1.2

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

225

1.69

2.45

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

173

1.79

2.45

1.3

—

(3025315) Body weight

2.55

2.44

5.7

5.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

622

1.40

2.42

1.1

—

3.5

—

(3045142) Bone marrow Pathology biopsy report

116

871

1.34

2.39

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

184

1469

1.26

2.39

1.5

1.3

iu/l

34.7

34.0

0.10

158

1259

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

267

2219

1.21

2.38

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.50

2.35

1.1

u/ml

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

122

926

1.32

2.34

1.1

iu/ml

69.1

1030.8

0.83

202

(3010375) cycloSPORINE [Mass/volume] in Blood

291

1.58

2.32

29.6

26.5

ug/l

116.4

108.7

0.47

243

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

628

1.39

2.30

1.4

1.3

nmol/l

1.7

1.5

0.67

563

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

113

851

1.33

2.29

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

406

1.48

2.25

1.7

2.4

e9/l

0.2

0.01

356

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

233

1923

1.22

2.25

2.3

ug/min

89.1

104.8

0.33

128

1134

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

113

1.95

2.24

1.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

127

976

1.31

2.24

2.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

107

804

1.34

2.22

1.4

1.3

u/l

923.2

346.7

0.46

100

757

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

393

3403

1.16

2.20

1.3

—

(3021901) Oxygen saturation in Capillary blood

181

1459

1.25

2.19

3.4

2.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

128

991

1.30

2.15

3.7

2.3

—

(3044290) Cell count panel - Cerebral spinal fluid

157

1248

1.26

2.15

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

107

810

1.33

2.12

1.1

121.6

115.9

1.04

713

(3002331) Protein [Mass/volume] in Peritoneal fluid

174

1.73

2.12

1.5

1.4

g/l

26.9

27.3

0.05

135

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

853

7779

1.11

2.12

3.7

3.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

118

907

1.31

2.10

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

138

1083

1.28

2.10

1.3

miu/ml

241.9

216.4

0.25

418

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

131

1022

1.29

2.09

1.4

1.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

191

1.68

2.05

1.2

1.6

g/l

12.9

13.6

0.16

154

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.50

2.05

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.02

2.05

6.1

4.7

—

(3041354) Potassium [Moles/volume] in Venous blood

129

1008

1.28

2.04

3.7

2.3

mmol/l

4.1

0.08

129

996

(3035285) Chloride [Moles/volume] in Venous blood

129

1008

1.28

2.04

3.7

2.3

mmol/l

105.8

105.6

0.14

129

996

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

366

1.48

2.04

2.4

3.5

—

(3002619) Bacteria identified in Specimen by Culture

132

1.82

2.03

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

1.2

1.1

—

(3024263) Appearance of Synovial fluid

401

1.45

1.99

1.8

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

477

1.41

1.97

1.4

nmol/l

0.3

0.2

0.17

348

(3051387) C reactive protein [Mass/volume] in Capillary blood

124

1574

0.78

1.96

4.1

3.7

mg/l

26.7

28.4

0.19

1011

(3022689) Creatine [Moles/volume] in Urine

202

1.64

1.94

1.3

1.4

—

(40768446) Kidney Pathology biopsy report

243

1.57

1.89

2.1

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

653

1.34

1.87

1.2

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

166

1.69

1.86

1.2

pmol/l

302.8

283.8

0.11

120

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.09

1.86

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.94

1.84

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

237

1.56

1.83

2.3

2.1

e6/l

3108.8

20601.2

1.24

126

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.12

1.81

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

101

1.88

1.80

1.5

1.3

73.8

73.2

0.03

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

564

6247

0.90

1.78

4.7

3.9

mmol/l

1.2

0.64

500

5434

(4015189)

231

1.56

1.78

2.1

2.2

—

(3011412) CD3 cells [#/volume] in Blood

642

1.33

1.77

1.8

2.3

e9/l

1.2

1.1

0.24

391

(4146454)

111

870

1.28

1.76

2.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

801

1.29

1.74

3.0

3.4

58.3

58.4

0.02

509

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

117

1.80

1.73

1.4

1.2

u/l

45.8

331.6

0.54

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

143

1160

1.24

1.71

1.3

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

194

1.60

1.71

1.2

1.3

g/l

0.3

0.49

155

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

1314

1.22

1.70

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

382

1.42

1.69

1.2

1.1

u/l

19.3

31.5

1.83

288

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

164

1353

1.22

1.67

1.3

e6/l

45.8

23.1

0.41

111

1034

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.38

1.67

2.6

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

728

1.29

1.65

1.5

1.3

e6/l

117038.1

146026.3

0.21

498

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

164

1355

1.21

1.65

1.4

e6/l

260.5

1358.9

3.44

119

1098

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

220

1.55

1.64

1.0

1.2

—

(4268621)

573

1.33

1.62

2.1

2.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

513

1.35

1.62

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

166

1.63

1.61

1.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

557

1.33

1.60

1.4

1.2

u/ml

62.3

77.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

244

2096

1.17

1.60

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.87

1.60

1.2

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.33

1.60

1.3

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.50

1.59

4.6

5.2

—

(3048879) Bone marrow aspiration report

246

1.51

1.59

1.6

1.8

—

(3044007) Cell count panel - Peritoneal fluid

215

1.54

1.56

2.5

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

272

1.47

1.55

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

305

1.44

1.55

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

372

1.40

1.55

2.8

2.6

34.5

36.9

0.36

137

(40768800) Prostate Pathology biopsy report

215

1835

1.18

1.54

1.1

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

561

1.32

1.54

1.4

1.2

u/ml

23.6

40.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

196

1662

1.18

1.52

1.6

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.59

1.51

1.3

1.1

nmol/l

179.6

280.9

—

(3032057) Clostridioides difficile [Presence] in Stool

177

1.58

1.51

2.4

1.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

108

1.76

1.50

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

383

1.39

1.50

1.2

1.1

u/l

78.6

89.4

0.70

297

(4133840)

154

1.63

1.49

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

401

1.37

1.48

7.6

12.3

—

(3038026) Centromere Ab [Units/volume] in Serum

574

1.31

1.47

1.4

1.2

u/ml

68.3

64.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

1055

1.23

1.47

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

276

1.45

1.46

1.5

1.4

umol/l

28.6

24.3

0.34

264

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.22

1.46

2.6

2.0

mg/l

25.1

18.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.37

1.45

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

171

1.58

1.45

1.4

1.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.50

1.45

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

2.73

1.43

1.7

1.6

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.73

1.43

1.8

2.0

mmol/l

4.1

4.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

404

1.36

1.42

1.2

mg/l

43.5

44.0

0.03

339

(3041918) Cholesterol [Moles/volume] in Pleural fluid

164

1.59

1.42

1.3

1.2

mmol/l

1.6

0.15

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

279

1.44

1.39

1.8

2.2

umol/l

59.9

55.8

0.26

225

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

712

1.27

1.39

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

238

1.47

1.38

2.9

umol/l

27.6

29.0

0.42

178

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

467

1.33

1.38

1.6

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

322

1.40

1.37

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

156

1312

1.19

1.36

3.0

3.5

1.9

1.5

0.51

127

1003

(4306422)

104

840

1.24

1.35

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

392

3525

1.12

1.35

1.2

iu/ml

103.4

134.9

1.16

150

1265

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

173

1470

1.18

1.35

1.7

iu/l

4.9

4.6

0.15

476

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

100

805

1.25

1.34

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

383

1.36

1.34

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

383

1.36

1.34

1.9

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

383

1.36

1.34

1.9

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

383

1.36

1.34

1.9

2.0

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.14

1.33

1.1

1.5

pmol/l

16.6

23.9

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.13

1.33

1.2

nmol/l

0.4

0.1

—

(3000034) Microalbumin [Mass/volume] in Urine

708

1.26

1.33

3.3

3.0

mg/l

52.7

39.1

0.27

527

(3020874) Milk IgE Ab [Units/volume] in Serum

208

1.49

1.32

1.1

u/ml

0.6

0.9

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.09

1.30

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.09

1.30

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

525

1.30

1.29

1.4

1.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

226

1.46

1.28

1.4

15.8

22.9

1.03

187

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

218

1.47

1.27

1.4

1.5

pmol/l

15.5

16.6

0.58

180

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

439

1.32

1.27

2.0

1.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

485

1.30

1.23

1.6

2.0

14.6

15.3

0.14

186

(3019897) Erythrocyte distribution width [Ratio] by Automated count

527

0.72

1.23

3.4

13.3

0.18

522

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

538

1.28

1.23

5.3

5.1

u/ml

114.7

69.9

0.31

153

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

149

1.55

1.16

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

394

1.32

1.15

6.6

6.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

150

1281

1.17

1.14

2.8

3.1

—

(3047189) Immunofixation for 24 hour Urine

404

1.31

1.13

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

112

933

1.20

1.13

1.7

1.5

65.0

60.5

0.58

589

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

301

1.36

1.12

2.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.12

3.0

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.90

1.12

1.2

1.6

—

(40761536) Microorganisms panel - Urine sediment

536

5793

0.92

1.11

4.9

4.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

127

1.58

1.11

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

1.56

1.11

1.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.26

1.10

10.9

9.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

138

0.51

1.09

1.0

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.73

1.08

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

252

1.39

1.08

2.6

1.9

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

702

1.23

1.07

1.8

1.5

24.2

29.7

0.86

441

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

295

1.36

1.07

1.5

1.7

nmol/l

6.5

6.3

0.02

251

(4281824)

749

1.22

1.05

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.71

1.05

1.9

2.1

—

(3025130) Human papilloma virus identified in Specimen

525

1.26

1.04

1.6

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

297

1.35

1.03

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.27

1.03

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.27

1.03

2.0

mg/l

4.2

2.8

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.27

1.03

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

1165

1.17

1.03

1.4

—

(3022475) Manganese [Moles/volume] in Blood

2.06

1.02

1.3

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.83

1.02

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.92

1.02

1.0

—

(3042631) Mycobacterium sp identified in Specimen

132

1130

1.17

1.01

2.7

—

(4027681)

290

1.35

1.00

1.4

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

404

1.29

1.00

1.5

1.6

u/l

8.2

6.1

0.30

337

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

300

1.33

0.98

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

300

1.33

0.98

2.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.80

0.98

1.1

1.0

—

(40768793) Breast Pathology biopsy report

159

1385

1.15

0.98

1.2

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.80

0.96

1.4

1.2

nmol/l

13.6

23.5

—

(1616796) Gas panel - Central venous blood

193

1708

1.13

0.95

4.4

3.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.77

0.94

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.94

1.2

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

158

1.46

0.93

1.1

1.2

77.4

86.2

0.50

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

260

1.35

0.92

1.1

u/ml

2.6

4.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

321

1.31

0.92

1.5

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.14

0.91

1.2

1.1

mmol/l

8.4

8.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.91

1.2

1.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

261

1.34

0.91

5.1

6.9

mmol/l

24.1

25.0

0.40

236

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

159

1.45

0.91

1.1

79.3

86.4

0.51

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

1.55

0.90

2.9

3.1

ng/l

35.2

160.3

—

(3019977) pH of Arterial blood

456

1.25

0.89

2.6

2.4

7.4

0.91

167

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.91

0.88

2.3

1.8

mg/l

1.9

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

324

1.30

0.87

1.6

1.4

64.5

66.8

0.21

265

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

298

1.31

0.87

1.2

1.1

u/l

1.0

1.1

0.71

143

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

169

1.42

0.87

2.7

2.3

mmol/l

6.7

8.0

1.51

104

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.00

0.87

1.8

1.5

mg/l

2.7

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

540

1.22

0.85

1.6

2.2

36.6

40.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

264

1.33

0.85

1.1

ng/l

569.4

348.6

—

(40765096) Chromosome analysis panel by Banding

230

1.35

0.84

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

649

6120

1.07

0.84

4.0

1.2

1.0

0.74

224

1841

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

318

1.29

0.83

1.0

1.1

iu/ml

5.2

11.1

2.71

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

139

0.58

0.83

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

489

0.78

0.82

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

1.51

0.82

1.1

u/ml

0.4

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

275

1.31

0.81

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

284

1.30

0.81

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.81

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

224

1.34

0.79

1.4

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.78

1.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

173

1.39

0.78

3.5

2.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

258

0.70

0.78

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

210

0.67

0.76

1.1

—

(3015183) Erythrocyte sedimentation rate

217

1.34

0.76

1.2

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.77

0.76

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1782

17290

1.04

0.75

4.1

3.6

—

(3029075) Extractable nuclear Ab panel - Serum

166

1.39

0.75

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

119

1041

1.15

0.74

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

2.08

0.74

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

351

1.25

0.74

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

167

1.38

0.73

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

193

1.35

0.73

11.8

8.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.80

0.72

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

185

1.35

0.71

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

407

1.23

0.71

2.2

2.1

ug/min

106.7

176.3

0.43

103

(3042010) Triglyceride [Moles/volume] in Pleural fluid

126

1.43

0.70

1.3

1.2

mmol/l

0.3

1.8

1.85

(3008757) Leukocyte morphology finding [Identifier] in Blood

851

1.15

0.69

3.8

4.2

—

(3014271) Vancomycin [Susceptibility]

454

1.21

0.69

2.7

2.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

759

1.16

0.68

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

204

1.32

0.68

1.8

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

136

1.40

0.66

1.4

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.54

0.65

1.9

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

207

1.31

0.63

1.8

2.9

—

(4212803)

1.52

0.62

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.62

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

142

1578

0.90

0.62

1.4

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.59

0.61

1.1

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.46

0.61

1.6

1.2

59.0

48.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

253

1.27

0.60

1.6

1.3

56.2

55.4

0.04

213

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

174

1.32

0.59

2.2

1.8

ug/l

2.6

5.3

0.74

117

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.59

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

127

1139

1.12

0.58

1.1

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.51

0.58

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

197

1809

1.09

0.57

1.8

1.7

mg/l

4.2

3.6

0.21

154

1305

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.48

0.57

1.4

4.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

410

1.20

0.57

3.7

3.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

411

1.19

0.56

2.2

2.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

187

1.28

0.52

1.9

1.6

ug/l

8.8

9.4

0.32

187

(3041806) Other cells [#/volume] in Blood by Manual count

1.50

0.51

1.3

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

161

1.31

0.51

1.1

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

772

1.13

0.50

1.1

—

(3008295) Osmolality of Serum or Plasma

754

1.13

0.49

1.2

1.3

mosm/kgh2o

281.1

278.0

0.74

576

(3021440) Promyelocytes/100 leukocytes in Blood

606

5813

1.05

0.49

4.1

0.2

0.66

205

1712

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

325

1.20

0.49

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.49

0.47

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

345

1.19

0.47

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

336

1.19

0.47

1.1

—

(3045716) Anion gap in Serum or Plasma

365

1.18

0.46

3.9

2.2

mmol/l

8.2

9.4

0.98

284

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

103

1.36

0.45

1.1

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

100

903

1.11

0.45

6.1

14.4

mmol/l

7.4

0.03

750

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

320

1.19

0.44

1.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

186

0.75

0.44

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

489

1.15

0.43

1.6

1.4

promille

1.4

1.2

0.46

376

(3036670) Protein [Mass/volume] in Synovial fluid

248

1.21

0.42

1.2

g/l

36.6

39.2

0.53

126

(4034850)

235

2209

1.07

0.42

12.1

10.8

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.56

0.42

1.0

1.2

—

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

249

2641

0.94

0.42

1.6

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

112

1023

1.10

0.41

1.8

2.3

31.9

32.8

1.09

112

1015

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.41

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.41

0.0

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

213

1.22

0.40

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

168

1.25

0.40

12.5

7.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

720

1.11

0.39

1.1

1.2

mmol/l

7.4

7.7

0.32

525

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

214

1.22

0.39

10.0

5.6

66.7

70.9

0.33

169

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

115

1.30

0.38

1.2

—

(3014891) Appearance of Pleural fluid

115

1.30

0.38

1.8

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

559

0.88

0.38

2.0

1.9

ug/l

4.4

3.6

0.32

490

(3010726) Horse dander IgE Ab [Units/volume] in Serum

551

1.13

0.38

1.1

u/ml

0.6

1.9

—

135

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.34

0.38

1.0

1.1

—

(4024509)

742

1.11

0.37

1.5

1.6

—

(3020650) Glucose [Presence] in Urine

158

0.76

0.37

1.2

1.5

—

(3017569) Oxygen content in Arterial blood

402

1.15

0.36

2.5

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

591

1.12

0.36

1.5

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

281

1.18

0.36

1.4

1.3

mmol/l

2.6

3.4

0.88

251

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

235

1.19

0.36

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

235

1.19

0.36

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

512

0.88

0.35

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

641

1.11

0.35

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

264

1.17

0.34

2.0

umol/l

88.8

129.2

0.90

147

(44806071)

1.37

0.34

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

642

1.11

0.34

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

163

1.23

0.34

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

145

1.24

0.33

1.0

1.8

ug/l

1.4

2.3

—

(40758292) HTLV I+II Ab panel - Serum

100

1.30

0.33

1.2

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

387

1.14

0.33

1.2

1.3

nmol/l

1.2

0.08

295

(3003888) Timothy IgE Ab [Units/volume] in Serum

644

1.10

0.33

1.0

1.1

u/ml

2.4

4.1

0.67

300

(3016750) Collection duration of Urine

435

1.13

0.32

2.3

2.1

min

494.2

493.5

0.02

319

(3036071) Salmonella sp Ab [Titer] in Serum

164

1.22

0.32

1.2

1.1

—

(3010503) CD19 cells [#/volume] in Blood

445

1.12

0.32

1.9

2.4

e9/l

0.3

0.2

0.09

426

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

146

1.23

0.32

1.6

ng/l

171.6

137.2

0.23

146

(40757373) Influenza virus identified in Isolate

154

0.78

0.32

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

248

1.17

0.31

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

174

1.21

0.31

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

352

1.14

0.30

1.6

1.5

5.4

3.9

—

(21494755) Public health laboratory ask at order entry panel

349

3627

0.96

0.30

1.4

—

(3019174) dRVVT (LA screen)

1.30

0.30

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

620

1.10

0.29

1.0

1.1

u/ml

0.4

1.2

1.71

256

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

157

1.21

0.29

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

477

1.11

0.29

1.0

1.1

u/ml

3.4

2.7

0.11

187

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.23

0.29

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

395

4087

0.96

0.28

1.9

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

450

0.89

0.28

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

167

1.20

0.28

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

488

1.11

0.28

1.1

mmol/l

27.4

34.7

1.79

419

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

151

0.79

0.28

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

129

0.77

0.28

1.1

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

449

0.89

0.27

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

140

1.21

0.27

1.6

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

547

1.10

0.27

1.0

ng/l

314.8

333.4

0.30

364

(3025577) Chromium [Mass/volume] in Blood

542

0.90

0.26

2.0

ug/l

2.2

2.3

0.06

452

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

187

1.18

0.26

1.1

—

(3028433) Virus identified in Specimen by Culture

244

1.15

0.25

1.5

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

549

1.09

0.25

1.0

ng/l

734.5

699.1

0.27

354

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

498

0.90

0.25

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

454

1.10

0.25

1.3

1.2

mmol/l

12.6

11.7

0.31

133

(3005011) Chlamydia sp Ab [Titer] in Serum

1.17

0.24

1.4

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.28

0.24

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

552

1.09

0.23

1.0

ng/l

51.2

44.4

0.34

359

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.32

0.23

1.2

3.9

—

0.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.28

0.23

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.28

0.23

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.28

0.23

4.2

3.8

—

(3010421) pH of Blood

193

2013

0.96

0.22

5.0

4.1

7.4

0.47

161

1702

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.25

0.22

1.2

ug/l

59.6

109.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

172

1.16

0.22

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

191

1.15

0.21

1.1

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

248

1.13

0.21

1.3

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

2761.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

740

1.07

0.21

1.1

u/ml

1.0

1.8

0.69

292

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

527

1.08

0.21

1.1

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(44806420)

240

0.87

0.20

2.0

2.4

—

(3044009) aPTT.lupus sensitive (LA screen)

1.25

0.20

1.0

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.20

0.19

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

193

1.14

0.19

1.2

1.3

nmol/l

133.5

140.4

0.07

143

(3039443) Prostate specific Ag panel - Serum or Plasma

130

1241

1.05

0.19

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.15

0.19

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

137

1.17

0.18

5.9

7.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

444

1.08

0.18

1.0

1.1

u/ml

5.8

2.8

0.27

176

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

630

0.94

0.17

1.5

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

591

1.07

0.17

1.6

u/ml

19.8

24.6

0.35

129

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

148

1.15

0.16

1.2

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.18

0.16

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

464

0.93

0.16

1.7

1.6

—

69.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.14

0.16

1.1

1.0

—

(4198724)

139

1.15

0.16

1.3

1.5

—

(3001729) Color of Synovial fluid

1.13

0.16

1.6

1.5

—

(3051101) Glucose [Moles/volume] in Cord blood

151

0.86

0.15

3.0

6.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.10

0.15

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.78

0.15

1.5

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.15

0.15

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.15

0.15

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.15

0.15

1.0

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

497

1.07

0.15

1.5

1.3

titre

46.7

72.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.13

0.15

1.3

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.10

0.15

1.1

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

563

5538

1.02

0.14

3.9

0.7

0.19

150

1322

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

170

0.88

0.13

2.9

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

249

1.08

0.11

1.8

2.0

—

(3013727) Leukocytes other/100 leukocytes in Blood

269

1.08

0.11

3.2

3.6

53.4

54.4

0.09

259

(3013290) Carbon dioxide [Partial pressure] in Blood

169

1734

0.97

0.11

5.3

4.2

kpa

5.1

5.0

0.54

161

1701

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

1.10

0.11

1.3

1.1

—

(3012501) Base excess in Blood by calculation

169

1732

0.98

0.10

5.3

4.2

mmol/l

2.9

2.6

0.53

116

1193

(3037692) Legionella sp identified in Specimen by Organism specific culture

270

0.93

0.10

1.2

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

617

0.96

0.10

1.6

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

135

0.89

0.09

2.8

3.1

—

(3025159) Blasts/100 leukocytes in Blood

549

5428

1.01

0.09

4.2

4.1

0.6

0.3

0.24

164

1444

(3016228) CD19 cells/100 cells in Blood

299

0.94

0.09

1.9

2.0

10.9

8.2

0.34

288

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

223

1.08

0.09

1.0

1.1

miu/ml

1515.9

1605.1

0.13

223

(3047352) Trisomy 18 risk [Likelihood] in Fetus

223

1.08

0.09

1.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.05

0.08

1.2

1.0

—

3.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.82

0.08

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

430

0.95

0.08

1.6

1.4

pmol/l

66.1

129.7

0.41

130

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

273

1.06

0.08

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

273

1.06

0.08

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

117

1.11

0.08

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

234

1.07

0.08

1.4

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.04

0.08

1.3

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.03

0.07

1.1

1.2

umol/24h

2.0

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.86

0.07

1.0

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.84

0.07

12.5

12.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.12

0.07

1.4

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

274

1.06

0.07

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

274

1.06

0.07

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.03

0.07

2.5

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

147

1.09

0.07

1.5

1.9

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.12

0.06

1.1

1.2

mmol/l

4.4

6.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

334

1.05

0.06

1.2

1.1

ratio

1.0

1.1

—

110

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

101

0.89

0.06

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

197

1.07

0.06

2.0

1.3

27.8

34.2

0.32

125

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

376

1.04

0.05

2.4

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

110

0.91

0.05

1.1

1.2

68.2

79.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

110

1.09

0.05

1.3

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

179

1.06

0.04

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

179

1.06

0.04

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

179

1.06

0.04

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

179

1.06

0.04

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

189

1.06

0.04

1.6

1.5

ug/l

0.3

0.4

0.66

113

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.10

0.04

1.2

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

166

1679

0.99

0.04

3.3

2.6

15.9

16.0

0.17

103

886

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

382

0.97

0.04

1.0

u/ml

0.1

0.3

—

105

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

517

1.03

0.04

1.4

1.3

titre

271.7

316.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

141

1.06

0.03

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

141

1.06

0.03

1.1

1.2

umol/24h

0.8

0.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

181

1.05

0.03

1.3

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

108

0.93

0.03

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

173

1744

0.99

0.02

5.3

4.2

kpa

8.3

8.5

0.83

165

1710

(3005033) Fetal Nuchal fold Thickness US

222

1.04

0.02

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

288

0.97

0.02

1.7

2.0

—

(3004451) EKG impression Narrative

408

0.98

0.01

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

253

1.03

0.01

1.2

1.3

ug/l

443.9

449.7

0.01

135

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

842

1.01

0.01

1.5

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

333

1.02

0.01

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

634

1.01

0.00

2.4

2.2

752.9

635.2

1.37

413

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

131

0.99

0.00

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

157

1.02

0.00

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

231

1.00

0.00

1.4

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

153

0.98

0.00

2.3

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

293

0.99

0.00

1.4

1.5

—

(3000012) Reticulocyte production index

455

0.99

0.00

1.3

1.5

—

(40768795) Lymph node Pathology biopsy report

733

1.00

0.00

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.04

0.00

1.4

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

132

0.98

0.00

1.7

1.4

6.1

8.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

338

1.01

0.00

1.1

—

(3034426) Prothrombin time (PT)

206

1.02

0.00

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.02

0.00

1.1

1.2

72.4

78.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

168

1.01

0.00

1.3

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.5

—

39.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

0.91

0.00

1.0

1.2

—

64.4

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.92

0.00

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.00

0.00

1.1

g/l

16.9

17.5

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

140.8

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.96

0.00

1.6

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.98

0.00

1.2

1.1

u/l

16.7

14.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.95

0.00

3.1

2.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.96

0.00

3.4

5.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.97

0.00

2.0

1.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

5.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.88

0.00

1.2

1.8

umol/l

12.2

17.8

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.9

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.96

0.00

1.8

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.02

0.00

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_RECTUM_ANAL and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_RECTUM_ANAL	1.132 [1.04, 1.23]	0.005
Birth year	0.996 [0.99, 1.0]	0.264

During the follow-up period (1.1.1998 — 31.12.2019), 3757 out of 17553 females with CD2_BENIGN_RECTUM_ANAL died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_RECTUM_ANAL	1.235 [1.13, 1.35]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 4969 out of 17500 males with CD2_BENIGN_RECTUM_ANAL died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_RECTUM_ANAL.

N-year risk	Females	Males
1	0.127%	0.226%
5	0.703%	1.476%
10	1.868%	3.671%
15	3.512%	6.876%
20	5.84%	11.146%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_RECTUM_ANAL – Benign neoplasm: Rectum, anus and anal canal

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Rectum, anus and anal canal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints